From 27–29 May 2026, Adamed Discovery participated in the ACCORD Interdisciplinary Conference on Drug Sciences at the Medical University of Warsaw. As a sponsor of the event, Adamed Pharma was proud to support a platform that brings together researchers and industry experts to advance drug discovery and development.

Our team actively contributed to the conference programme. Maria Mazur delivered a lecture entitled “AD-O51: From Preclinical Rationale to the Clinical Development of an Apoptosis-Targeting Anticancer Therapy”,  while Michał Szymanik and Damian Graczyk welcomed visitors at the Adamed Pharma booth, presenting our research activities and discussing potential collaborations.

We would like to thank the organizers and participants for the inspiring discussions and valuable networking opportunities.